Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Andrea Cortegiani; Dario Nicosia; Giovanni Misseri; Pasquale Iozzo

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Andrea Cortegiani, Dario Nicosia, Giovanni Misseri, Pasquale Iozzo

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Article › peer review

Abstract

In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

Lingua originale	English
pagine (da-a)	665-667
Numero di pagine	3
Rivista	Clinical Case Reports
Volume	7
Stato di pubblicazione	Published - 2019

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2700???

Altri file e collegamenti

OA Link

Cita questo

@article{5f77c5c35db2478c8ce1a095a78579dc,

title = "Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy",

abstract = "In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.",

author = "Andrea Cortegiani and Dario Nicosia and Giovanni Misseri and Pasquale Iozzo",

year = "2019",

language = "English",

volume = "7",

pages = "665--667",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

AU - Cortegiani, Andrea

AU - Nicosia, Dario

AU - Misseri, Giovanni

AU - Iozzo, Pasquale

PY - 2019

Y1 - 2019

N2 - In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

AB - In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

UR - http://hdl.handle.net/10447/408940

M3 - Article

SN - 2050-0904

VL - 7

SP - 665

EP - 667

JO - Clinical Case Reports

JF - Clinical Case Reports

ER -

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo